Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000930413-10-000676
Filing Date
2010-02-10
Accepted
2010-02-10 12:23:37
Documents
1
Period of Report
2010-01-29

Document Format Files

Seq Description Document Type Size
1 c60279_ex.html 3  
1 c60279_ex.xml 3 1425
  Complete submission text file 0000930413-10-000676.txt   3172
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Issuer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O ENZO BIOCHEM, INC. 527 MADISON AVENUE NEW YORK NY 10022
Business Address
BORTZ GREGORY M. (Reporting) CIK: 0001483164 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-09974 | Film No.: 10586949